Loading...
Indian Pharmaceutical Exporter · #10 for Diclofenac · $2.1M export value · DGFT Verified
Sifam Healthcare Private Limited is the #10 Indian exporter of Diclofenac with $2.1M in export value and 42 verified shipments. Sifam Healthcare Private Limited holds a 0.6% market share in Diclofenac exports across 5 countries.
| $73.1K |
| 2 |
| 7.6% |
| SOMALIA | $50.0K | 1 | 5.2% |
| LIBERIA | $3.7K | 1 | 0.4% |
Sifam Healthcare Private Limited exports Diclofenac to 7 countries. The largest destination is SOMAALIA accounting for 35.5% of Sifam Healthcare Private Limited's Diclofenac shipments, followed by BENIN (26.4%) and CAMEROON (15.0%). These destinations reflect Sifam Healthcare Private Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | CAMEROON | $51.3K | 17 |
| CENTRAL BANK | NIGERIA | $37.2K | 1 |
Sifam Healthcare Private Limited supplies Diclofenac to 2 buyers globally. The largest buyer is TO THE ORDER (CAMEROON). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $119.5M worth of Diclofenac through 15,000 shipments from 1007 suppliers to 173 countries, serving 2,731 buyers globally. Sifam Healthcare Private Limited contributes $2.1M to this total, accounting for 0.6% of India's Diclofenac exports. Sifam Healthcare Private Limited ships Diclofenac to 7 countries through 2 buyers.
Sifam Healthcare Private Limited's average Diclofenac shipment value is $50.0K per consignment, based on 42 shipments totaling $2.1M. The largest destination is SOMAALIA (35.5% of Sifam Healthcare Private Limited's Diclofenac exports).
Sifam Healthcare Private Limited ranks #10 among 1007 Indian Diclofenac exporters with a 0.6% market share. The top 3 exporters are CIPLA LIMITED ($20.9M), TROIKAA PHARMACEUTICALS LIMITED ($16.0M), CAPLIN POINT LABORATORIES LIMITED ($15.5M). Sifam Healthcare Private Limited processed 42 shipments to 5 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| Paracetamol ,Diclofenac Sodium And Caffi | $245.9K | 5 |
| Diclofenac 50 mg Tablets DICLOSIF Batch | $133.1K | 3 |
| Diclofenac Sodium BP 50 mg Tablet SIFED | $113.4K | 3 |
| 1. Paracetamol ,Diclofenac Sodium And Caffine Tablets Tethomol B.No.TXL05 To TXL09 Mfg.Dt.:12-2024 Exp. Dt:11-2027 B.No | $50.0K | 1 |
| PARACETAMOL ,DICLOFENAC SODIUM AND CAFFINE TABLETS TETHOMOL B.NO. TWI01 TO TWI05MFG. DT. : 09-2023 , EXP. DT.: 08-2026NOS | $49.6K | 3 |
| PARACETAMOL ,DICLOFENAC SODIUM AND CAFFINE TABLETS TETHOMOL B.NO. TXC04 TO TXC08MFG. DT. : 03-2024 , EXP. DT.: 02-2027 | $45.0K | 1 |
| Diclofenac Tablets BP 50 MG Sifam Relax | $45.0K | 7 |
| Diclofenac 50 mg Tablet DICLOSUITE, DYS | $43.8K | 3 |
| Diclofenac Potassium 50 mg Tablets BIOFENAC 50 B.No. TWF08 To TWF14 MANUFACTURING . Dt. 06-2023 , Exp. Dt.05-2026 | $37.2K | 1 |
| Diclofenac Potassium 50 mg Tablets BIOFE | $35.9K | 1 |
Sifam Healthcare Private Limited exports 32 distinct Diclofenac formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Paracetamol ,Diclofenac Sodium And Caffi with 5 shipments worth $245.9K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 15 | SOCOMED PHARMA PRIVATE LIMITED | $3.2M | 150 | 11 | $21.2K |
| 11 | BAL PHARMA LIMITED | $2.3M | 45 | 9 | $50.0K |
| 10 | SIFAM HEALTHCARE PRIVATE LIMITED ★ | $2.1M | 42 | 5 | $50.0K |
| 14 | ALEMBIC PHARMACEUTICALS LIMITED | $1.9M | 38 | 1 | $50.0K |
| 12 | SANGHARSH LIFECARE PRIVATE LIMITED | $1.2M | 24 | 3 | $50.0K |
Sifam Healthcare Private Limited ranks #10 among 1007 Indian Diclofenac exporters. Average shipment value of $50.0K compared to the market average of $118.7K. The closest competitors by value are SOCOMED PHARMA PRIVATE LIMITED and BAL PHARMA LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 2,481 | 16.5% |
| JNPT/ NHAVA SHEVA SEA | 1,272 | 8.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,186 | 7.9% |
| SAHAR AIR | 903 | 6.0% |
| JNPT | 712 | 4.7% |
| DELHI AIR CARGO ACC (INDEL4) | 679 | 4.5% |
| NHAVA SHEVA | 676 | 4.5% |
| Bombay Air | 491 | 3.3% |
Latest developments and market context
Detailed market intelligence for Diclofenac — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 173+ countries, 2,731+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sifam Healthcare Private Limited's Diclofenac exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sifam Healthcare Private Limited
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Sifam Healthcare Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Diclofenac. For current shipment-level data, contact TransData Nexus.